The Global Pharmaceutical Market – Challenges of Internationalizing

Foley is pleased to invite you to a roundtable discussion of the challenges and opportunities presented by the unprecedented growth of the global pharmaceutical market. This interactive session will be moderated by Foley Partners Stephen A. Bent, founder of the firm’s Life Sciences Industry Team, and Nathan Beaver. Stephen and Nathan also have invited to join the discussion a key player in the new China initiative launched by the U.S. Food and Drug Administration (FDA).

Stephen has gained internationally recognized experience in intellectual property (IP) issues relating to biopharmaceuticals.

The roundtable moderators will lead a candid discussion of IP and regulatory topics of critical importance to Chinese companies, including:

• The regulatory climate — safety considerations and their impact on product approval
• Understanding IP risks in the international pharmaceutical market
• The development, production, and commercialization of biologics
• Effective partnering in the international health care space

This roundtable is part of Foley’s Shanghai Office Roundtable Series, designed to help top-level executives explore hot-button issues impacting the fastest-growing Chinese markets.

To view additional events in this series, please visit the event pages below.

• June 4, 2008
  China's Evolving Role in the Global Automotive Industry (view event page)
• June 5, 2008
  China’s Evolving Business Landscape (view event page)
• June 6, 2008
  Intellectual Property: Going Beyond the Basics (view event page)

If you have questions about this roundtable or others in the series, please contact Jackie Polson at jpolson@foley.com or 407.244.3228.